Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
0.9474
+0.0301 (3.28%)
Aug 3, 2026, 11:48 AM EDT - Market open
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $388.19 million as of August 3, 2026. Its market cap has increased by 99.58% in one year.
Market Cap
388.19M
Enterprise Value
326.24M
1-Year Change
99.58%
Ranking
Category
Stock Price
$0.95
ChartMarket Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $388.19M, a decrease of -93.15%. That is a compound annual growth rate of -27.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 387.10M | -0.77% |
| Dec 31, 2025 | 390.10M | 35.12% |
| Dec 31, 2024 | 288.70M | -31.86% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
| May 24, 2018 | 5.67B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tilray Brands | 615.69M |
| Aquestive Therapeutics | 463.60M |
| Kamada | 418.44M |
| BioAge Labs | 401.85M |
| Evolus | 384.59M |
| Emergent BioSolutions | 372.53M |
| Akebia Therapeutics | 354.10M |
| Organogenesis Holdings | 304.96M |